ReviewPharmacoEconomics2003
Cost of illness of atopic dermatitis in children: a societal perspective.
Review in PharmacoEconomics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 6 syntheses or guidelines pooled it, 116 citations in OpenAlex.
- Topical anti-inflammatory treatments for eczema: network meta-analysis.The Cochrane database of systematic reviews · 2024Pooled it
- Efficacy of health education on treatment of children with atopic dermatitis: a meta-analysis of randomized controlled trials.Archives of dermatological research · 2020Pooled it
- House dust mite reduction and avoidance measures for treating eczema.The Cochrane database of systematic reviews · 2015Pooled it
- Psychological and educational interventions for atopic eczema in children.The Cochrane database of systematic reviews · 2014Pooled it
- Dietary supplements for established atopic eczema.The Cochrane database of systematic reviews · 2012Pooled it
- Dietary exclusions for established atopic eczema.The Cochrane database of systematic reviews · 2008Pooled it
- Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Trial
- Trial
- Effects of probiotics on atopic dermatitis: a randomised controlled trial.Archives of disease in childhood · 2005Trial
- Oral administration ofFrontiers in microbiology · 2025Article
- The importance of registries in clinical practice: Insights from the national atopic dermatitis registry TREATgermany.Allergologie select · 2025Article
- Unveiling the mechanism of essential oil action against skin pathogens: from ancient wisdom to modern science.Archives of microbiology · 2024Review
- Article
- Unmet Medical Needs and Early Referral of Pediatric Atopic Dermatitis: An Expert Modified Delphi Consensus from Saudi Arabia.Dermatology research and practice · 2022Article
- Managing Atopic Dermatitis with Lebrikizumab - The Evidence to Date.Clinical, cosmetic and investigational dermatology · 2022Review
- Prevalence and Comorbidity of Atopic Dermatitis in Children: A Large-Scale Population Study Based on Real-World Data.Journal of clinical medicine · 2020Article
- Article
- A bibliometric analysis of two decades of aromatherapy research.BMC research notes · 2017Article
- Consensus Conference on Clinical Management of pediatric Atopic Dermatitis.Italian journal of pediatrics · 2016Review
- Efficacy of topical azathioprine and betamethasone versus betamethasone-only emollient cream in 2-18 years old patients with moderate-to-severe atopic dermatitis: A randomized controlled trial.Advanced biomedical research · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Childhood atopic dermatitis is a disorder with considerable social and financial costs. Consideration of these costs is increasingly important in view of the growing prevalence of atopic dermatitis, particularly in developed countries over recent decades. The family stress related to the care of children with moderate or severe atopic dermatitis is significantly greater than that of the care of children with type 1 diabetes mellitus. The factors contributing to family stress include sleep deprivation, loss of employment, time taken for care of atopic dermatitis and financial costs. The financial costs for the family and community include medical and hospital direct costs of treatments and indirect costs from loss of employment. There are many interventions utilised in the treatment of childhood atopic dermatitis which involve not only medical practitioners but nurses, pharmacists, dieticians, psychologists and purveyors of so-called alternative therapies such as naturopathy, aromatherapy and bioresonance, all of which contribute to the financial burdens on the parents and the community. It is possible that appropriate interventions directed to reducing trigger factors might produce worthwhile savings, although the cost benefit of these measures has not been demonstrated. In conclusion, atopic dermatitis should not be regarded as a minor skin disorder but as a condition which has the potential to be a major handicap with considerable personal, social and financial consequences both to the family and the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.